D+125
Today is  2025. 04. 03.

Program

07:00 - 08:00 Breakfast Symposium [ Daiichi-Sankyo ]
07:00 - 08:00
Breakfast Symposium [ Daiichi-Sankyo ]

Chairperson

Sang-Hyun Ihm (The Catholic University of Korea, Korea)

07:00 - 08:00

A Practical Approach to Hypertension Management in Elderly Patients

Hack-Lyoung Kim (Seoul National University, Korea)

08:00 - 08:30

Break

08:30 - 10:10 Symposium 7
What SGLT2 Inhibitors have Changed in Our Field - Multidisciplinary Perspectives
08:30 - 10:10
Symposium 7
What SGLT2 Inhibitors have Changed in Our Field - Multidisciplinary Perspectives

Organizer : Jong-Chan Youn (The Catholic University of Korea, Korea)

  • In this multidisciplinary session, we begin with an exploration of the known and unknown mechanisms of SGLT2 inhibitors, providing a foundational understanding of their function and impact.
  • Next, we will hear from leading experts in various fields: diabetologists will discuss the transformative effects of SGLT2 inhibitors on diabetes management, cardiologists will share insights into cardiovascular benefits, and nephrologists will examine the implications for kidney health.

Chairpersons

Hae-Young Lee (Seoul National University, Korea)
Jae Hyuk Lee (Myongji Hospital, Korea)

08:30 - 08:50

The Known and Unknown Mechanisms of SGLT2 Inhibitors

Yong-ho Lee (Yonsei University, Korea)

08:50 - 09:10

What SGLT2 Inhibitors have Changed in Our Field - Diabetologist's Perspectives

Eun Young Lee (The Catholic University of Korea, Korea)

09:10 - 09:30

What SGLT2 Inhibitors have Changed in Our Field - Cardiologist's Perspectives

Dong-Hyuk Cho (Korea University, Korea)

09:30 - 09:50

What SGLT2 Inhibitors have Changed in Our Field - Nephrologist's Perspectives

Hyung Duk Kim (The Catholic University of Korea, Korea)

09:50 - 10:10

Panel Discussion

Jinhwa Kim (Chosun University, Korea), Yuran Ahn (The Catholic University of Korea, Korea)

Hanbi Lee (The Catholic University of Korea, Korea), Jiyeon Hong (Hallym University, Korea)

10:10 - 10:30

Coffee Break

10:30 - 11:10 Plenary Lecture 3
10:30 - 11:10
Plenary Lecture 3

Chairpersons

Sang Hong Baek (The Catholic University of Korea, Korea)

10:30 - 11:10

The Role of SGLT2i in Integrative Management of Cardio-Renal-Metabolic Diseases

David Cherney (University Health Network & Mount Sinai Hospitals, Canada)

11:10 - 12:50 Symposium 9
Obesity and Cardiovascular Disease
11:10 - 12:50
Symposium 9
Obesity and Cardiovascular Disease

Organizer : Jong-Chan Youn (The Catholic University of Korea, Korea)

  • In this session, we will explore the intricate link between these two critical health conditions. Our program begins with an overview of obesity, its definition, and clinical implications, setting the stage for understanding its impact on cardiovascular health. We'll then delve into the intriguing obesity paradox in cardiovascular disease, followed by insights into the role of bariatric surgery for obese patients with cardiovascular conditions. Finally, we will discuss the latest advancements in pharmacotherapy for these patients.

Chairpersons

Hyuk-Sang Kwon (The Catholic University of Korea, Korea)
Sang-Hak Lee (Yonsei University, Korea)

11:10 - 11:30

Obesity: Definition and Clinical Implications

Sang Woo Oh (Dongguk University, Korea)

11:30 - 11:50

Obesity Paradox in Cardiovascular Disease

Darae Kim (Sungkyunkwan University, Korea)

11:50 - 12:10

Bariatric Surgery for Obese Patients with Cardiovascular Disease

Moon-Won Yoo (University of Ulsan, Korea)

12:10 - 12:30

Novel Pharmacotherapy for Obese Patients with Cardiovascular Disease

Soo Lim (Seoul National University, Korea)

12:30 - 12:50

Panel Discussion

Dae Young Cheon (Hallym University, Korea), Junho Hyun (University of Ulsan, Korea)

Yeoree Yang (The Catholic University of Korea, Korea), Mihae Seo (Soonchunhyang University, Korea)

12:50 - 13:30 Luncheon Symposium 3 [ Daewoong Bio Incorporated ]
12:50 - 13:30
Luncheon Symposium 3 [ Daewoong Bio Incorporated ]

Chairperson

Byung Jin Kim (Sungkyunkwan University, Korea)

12:50 - 13:10

[ICOSA] Clinical Value of EPA

Dae Young Cheon (Hallym University, Korea)

13:10-13:40

Break

13:50 - 14:30 Plenary Lecture 4
13:50 - 14:30
Plenary Lecture 4
  • The carotid intima‑media thickness test (CIMT) is a measure used to diagnose the extent of carotid atherosclerotic vascular disease. The test measures the thickness of the inner two layers of the carotid artery—the intima and media—and alerts physicians to any thickening when patients are still asymptomatic. CIMT shows good correlation with the extent of one person’s atherosclerotic disease and predicts future cardiovascular events. CIMT is non-invasive and could be easily performed in the clinic for the prediction of atherosclerotic disease in our patients. In this plenary lecture, Prof. Yong-Jae Kim from The Catholic University of Korea will tell us about the role of CIMT in the risk stratification of cardiovascular risk.

Chairpersons

Sang-Hyun Ihm (The Catholic University of Korea, Korea)

13:50 - 14:30

Black and White: The Evolving Role of Carotid Intima-Media Thickness in Risk Stratification

Yong-Jae Kim (The Catholic University of Korea, Korea)

14:30 - 14:50

Coffee Break

14:50 - 16:10 Symposium 11
Lifestyle Modification for Prevention of Cardiovascular Disease (K)
14:50 - 16:10
Symposium 11
Lifestyle Modification for Prevention of Cardiovascular Disease (K)

Chairpersons

Sung Hee Choi (Seoul National University, Korea)
Min Kyong Moon (Seoul National University, Korea)

14:50 - 15:10

Physical Activity for Prevention of Cardiovascular Disease: Consensus Statement of Korean Society of Cardiovascular Disease Prevention

Ye Seul Yang (Seoul National University, Korea)

15:10 - 15:30

Lifestyle Modification Program of the Korean Diabetes Prevention Study and Its Application in Clinical Practice

Suk Chon (Kyung Hee University, Korea)

15:30 - 15:50

Beyond Diet and Exercise: Hidden Lifestyle Factors in CVD Prevention

Eu Jeong Ku (Seoul National University, Korea)

15:50 - 16:10

Panel Discussion

In-Kyung Jeong (Kyung Hee University, Korea), Ga Eun Nam (Korea University, Korea)

Kye-Yeung Park (Hanyang University, Korea), Jung Ah Lee (University of Ulsan, Korea)

16:10 - 16:30

Break

16:30 - 16:50 Closing Ceremony
16:30 - 16:50
Closing Ceremony
08:30 - 10:10 Symposium 8
Non-Traditional Risk Factors of Cardiovascular Disease
08:30 - 10:10
Symposium 8
Non-Traditional Risk Factors of Cardiovascular Disease

Chairpersons

Jin Wi (Gachon University, Korea)
Hun-Jun Park (The Catholic University of Korea, Korea)

08:30 - 08:50

Cardiovascular Risk in Breast Cancer Survivorship: Latest Findings

Yong-Moon Mark Park (University of Arkansas for Medical Sciences, USA)

08:50 - 09:10

Sleep and Cardiovascular Disease

Jung Kyung Hong (Seoul National University, Korea)

09:10 - 09:30

Synergistic Effect of Lipoprotein (a) and C-reactive Protein on Prognosis of Familial Hypercholesterolemia

Hayato Tada (Kanazawa University, Japan)

09:30 - 09:50

Cancer Treatment as a Possible Risk Factor for Cardiovascular Disease

Woo-Baek Chung (The Catholic University of Korea, Korea)

09:50 - 10:10

Panel Discussion

Dughyun Choi (Soonchunhyang University, Korea), Hyo-In Choi (Sungkyunkwan University, Korea)

Hwi Seung Kim (Chung-Ang University, Korea), Junho Hyun (University of Ulsan, Korea)

10:10 - 10:30

Coffee Break

10:30 - 11:10 Plenary Lecture 3
10:30 - 11:10
Plenary Lecture 3

Chairpersons

Sang Hong Baek (The Catholic University of Korea, Korea)

10:30 - 11:10

The Role of SGLT2i in Integrative Management of Cardio-Renal-Metabolic Diseases

David Cherney (University Health Network & Mount Sinai Hospitals, Canada)

11:10 - 12:50 Symposium 10
Regional, Social Disparities in CV and Metabolic Health Outcomes
11:10 - 12:50
Symposium 10
Regional, Social Disparities in CV and Metabolic Health Outcomes

Organizer : Seung-Hyun Ko (The Catholic University of Korea, Korea)

  • Cardiometabolic diseases are major health issues all around the world, especially in Korea, and standard guidelines for the average person continue to evolve. However, health disparities in certain groups still exist, and efforts to resolve them are on-going. This session explores the uneven distribution of these conditions across different social and regional factors, examining how factors such as socioeconomic status, urbanization, and access to healthcare influence these disparities. By understanding the underlying causes and regional differences, we aim to develop targeted interventions and policies to alleviate these disparities, improve public health outcomes, and ensure equitable healthcare access for all Koreans.

Chairpersons

Sung Kee Ryu (Ewha Womans University, Korea)
Masayuki Yoshida (Tokyo Medical and Dental University, Japan)

11:10 - 11:30

Cardiovascular and Renal Health Outcomes in Single-Person Households

Seung-Hwan Lee (The Catholic University of Korea, Korea)

11:30 - 11:50

Regional Disparities in Prehospital Delay of Acute Ischemic Stroke

Keun-Hwa Jung (Seoul National University, Korea)

11:50 - 12:10

Disparities in Mortality and Cardiovascular Events by Income and Blood Pressure Levels Among Patients with Hypertension in South Korea

Ki-Chul Sung (Sungkyunkwan University, Korea)

12:10 - 12:30

Increasing Disparities in Diabetes Mellitus Prevalence Among People with Disabilities in South Korea

Inha Jung (Korea University, Korea)

12:30 - 12:50

Panel Discussion

Han Na Jang (Sungkyunkwan University, Korea), Hae Kyung Kim (Yonsei University, Korea)

Sungjin Chung (The Catholic University of Korea, Korea), Hyun-Jin Kim (Hanyang University, Korea)

12:50 - 13:30 Luncheon Symposium 4 [Celltrion & Boryung ]
12:50 - 13:30
Luncheon Symposium 4 [Celltrion & Boryung ]

Chairperson

Chong Hwa Kim (Bucheon Sejong Hospital, Korea)

12:50 - 13:10

Reappraisal of TZD to Control Diabetes: Pioglitazone

Chang Hee Jung (University of Ulsan, Korea)

13:10 - 13:30

What is the Best Combination Therapy for Korean T2DM Patients?

Seung-Hwan Lee (The Catholic University of Korea, Korea)

13:30 - 13:50

Break

13:50 - 14:30 Plenary Lecture 4
13:50 - 14:30
Plenary Lecture 4
  • The carotid intima‑media thickness test (CIMT) is a measure used to diagnose the extent of carotid atherosclerotic vascular disease. The test measures the thickness of the inner two layers of the carotid artery—the intima and media—and alerts physicians to any thickening when patients are still asymptomatic. CIMT shows good correlation with the extent of one person’s atherosclerotic disease and predicts future cardiovascular events. CIMT is non-invasive and could be easily performed in the clinic for the prediction of atherosclerotic disease in our patients. In this plenary lecture, Prof. Yong-Jae Kim from The Catholic University of Korea will tell us about the role of CIMT in the risk stratification of cardiovascular risk.

Chairpersons

Sang-Hyun Ihm (The Catholic University of Korea, Korea)

13:50 - 14:30

Black and White: The Evolving Role of Carotid Intima-Media Thickness in Risk Stratification

Yong-Jae Kim (The Catholic University of Korea, Korea)

14:30 - 14:50

Coffee Break

14:50 - 16:30 Symposium 12
Digital Healthcare (K)
14:50 - 16:30
Symposium 12
Digital Healthcare (K)

Chairpersons

Seung-Hyun Ko (The Catholic University of Korea, Korea)
Jae Hyoung Cho (The Catholic University of Korea, Korea)

14:50 - 15:10

Bird View of Digital Health in Arrythmia & HF

Seonghoon Choi (Hallym University, Korea)

15:10 - 15:30

From Doctor to Doctorpreneur: Initial Software Platform Company Building Experience

Su Jeong Song (Sungkyunkwan University, Korea)

15:30 - 15:50

Generative AI in Medicine: Unleashing the Power of Diffusion Models

Chi Hoon Lee (CJ Corporation, Korea)

15:50 - 16:10

Digital Biomarker and Digital Therapeutics for Patients with Cognitive Impairment

Geon Ha Kim (Ewha Womans University, Korea)

16:10 - 16:30

Panel Discussion

Sang Youl Rhee (Kyung Hee University, Korea), Joong-Wha Chung (Chosun University, Korea)

Dae-Jeong Koo (Changwon Fatima Hospital, Korea), Jaemin Shin (Medi Plus Solution Co., Ltd., Korea)

16:30 - 16:50 Closing Ceremony
16:30 - 16:50
Closing Ceremony